LIFEMD INC (LFMD)

LifeMD to Report First Quarter 2024 Financial Results on May 8

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its...

Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.

LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management...

Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.

DexCom Stock Trying To Close In On Key Technical Benchmark

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.

3 Stocks That Could Benefit from the Rise of Telemedicine

With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.

LifeMD Reports Fourth Quarter 2023 Results

Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of...

Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains

These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.

LifeMD Series A Cumulative Perpetual Preferred Stock Crosses Above 12% Yield Territory

LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in...

LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in...

LifeMD stock jumps on upbeat 2024 revenue forecast (NASDAQ:LFMD)

LifeMD expects 2024 revenue to be $195M-$205M, exceeding analysts' expectations.

Eli Lilly stock gains, LifeMD, WW stocks down on LillyDirect

Shares of WW International (WW) and LifeMD (LFMD) fell Thursday as Eli Lilly (LLY) launched LillyDirect, an online offering for obesity drugs. Read more here.

RSI Alert: LifeMD (LFMD) Now Oversold

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™ (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its...

7 Small-Cap Stocks That Wall Street Loves for Good Reason

The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!

LifeMD and Medifast Partner to Offer Transformative Weight Management Solution

Collaboration will integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle...

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation...

LifeMD Series A Cumulative Perpetual Preferred Stock Yield Pushes Past 12%

(NASDAQ:LFMD)

LifeMD, Inc. reported impressive Q3 results, with non-GAAP EPS of $0.08 beating estimates by $0.05 and revenue of $38.6M surpassing expectations by $0.43M.